Event Brief
Florida AG sues over insulin and diabetes drug prices
By The BriefBrief · Sources (1)
Filed: Sep 22, 2026 at 6:00 PM ET
Summary: Florida Attorney General James Uthmeier announced a lawsuit in Tampa targeting high insulin and diabetes-related drug prices. The case names insulin makers Eli Lilly, Novo Nordisk and Sanofi, plus PBMs CVS Caremark, Express Scripts and Optum Rx, and rebate aggregators Zinc, Ascent and Emisar.
WHO: Florida Attorney General James Uthmeier; defendants include Eli Lilly, Novo Nordisk, Sanofi, CVS Caremark, Express Scripts, Optum Rx, Zinc, Ascent and Emisar.
WHAT: Uthmeier filed a lawsuit alleging price-fixing, anti-competitive behavior and deceptive trade practices involving insulin and diabetes-related drugs, including GLP-1s.
WHEN: Sep 22, 2026
WHERE: Tampa, Florida
WHY: No specific cause was reported beyond the event itself.
How this brief is built: The BriefBrief uses multi-source information fusion to correlate reporting across sources, identify related developments, and continuously update a structured WHO, WHAT, WHEN, WHERE and WHY event picture. Pattern arcs, source analysis, and velocity indicators provide deeper analysis in our MI Console.
Knoxville sex offender heads to court for restriction violation
Sex Offender
Sep 22, 2026 at 6:00 PM ET
Driver, juvenile hurt in Rockwood crash
Knoxville
Sep 22, 2026 at 6:00 PM ET
Loudon County weighs rules for license plate readers
Loudon County
Sep 22, 2026 at 6:00 PM ET
Sarasota leaders get positive Midnight Pass update
Midnight Pass
Sep 22, 2026 at 6:00 PM ET
